| scholarly article | Q13442814 |
| P50 | author | Neetu M Gulati | Q88589569 |
| Audray K Harris | Q88811197 | ||
| P2093 | author name string | John R Gallagher | |
| Dustin M McCraw | |||
| Mallory L Myers | |||
| Michael T Conlon | |||
| Udana Torian | |||
| P2860 | cites work | M2-based influenza vaccines: recent advances and clinical potential | Q40571808 |
| Cryomicroscopy provides structural snapshots of influenza virus membrane fusion. | Q40584230 | ||
| Reverse genetics studies on the filamentous morphology of influenza A virus | Q40668357 | ||
| Viral receptor-binding site antibodies with diverse germline origins | Q40955071 | ||
| Papillomavirus-like particles and HPV vaccine development | Q41585272 | ||
| Electron microscopy of influenza virus. A comparison of negatively stained and ice-embedded particles | Q41636303 | ||
| THE ANTIGENIC POTENCY OF EPIDEMIC INFLUENZA VIRUS FOLLOWING INACTIVATION BY ULTRAVIOLET RADIATION. | Q41816583 | ||
| The structure of influenza virus. I. The polypeptides of the virion | Q43853856 | ||
| Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus | Q44749961 | ||
| ENHANCEMENT OF THE IMMUNIZING CAPACITY OF INFLUENZA VIRUS VACCINES WITH ADJUVANTS. | Q45400589 | ||
| Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virus, purified polypeptides, or polypeptide micelles | Q45792592 | ||
| Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies | Q45805667 | ||
| Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus | Q45809047 | ||
| The structure of influenza virus. II. A model based on the morphology and composition of subviral particles | Q45827310 | ||
| Influenza vaccine: split-product versus whole-virus types--How do they differ | Q45888201 | ||
| The Pathway to a Universal Influenza Vaccine | Q46177868 | ||
| Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines | Q47130066 | ||
| Evolution of a designed protein assembly encapsulating its own RNA genome. | Q47253184 | ||
| Dissection of epitope-specific mechanisms of neutralization of influenza virus by intact IgG and Fab fragments | Q47562645 | ||
| Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha | Q47606834 | ||
| Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza | Q21091074 | ||
| Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus | Q23921202 | ||
| Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo | Q24568302 | ||
| Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males | Q24614644 | ||
| The biology of influenza viruses | Q24620598 | ||
| A highly conserved neutralizing epitope on group 2 influenza A viruses | Q24630467 | ||
| Antibody recognition of a highly conserved influenza virus epitope | Q24655932 | ||
| Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies | Q26823492 | ||
| Mechanisms of hemagglutinin targeted influenza virus neutralization | Q27302234 | ||
| Antibodies with 'Original Antigenic Sin' Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses | Q27312311 | ||
| Cryotomography of budding influenza A virus reveals filaments with diverse morphologies that mostly do not bear a genome at their distal end | Q27334559 | ||
| Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses | Q27644544 | ||
| Molecular architecture of native HIV-1 gp120 trimers | Q27651385 | ||
| Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus | Q27660330 | ||
| Highly Conserved Protective Epitopes on Influenza B Viruses | Q27671404 | ||
| FDA approves Gardasil 9 for more types of HPV. | Q51034814 | ||
| Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies. | Q52602393 | ||
| Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy. | Q52650775 | ||
| A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases. | Q54262077 | ||
| The temperature-sensitive and attenuation phenotypes conferred by mutations in the influenza virus PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A | Q54690394 | ||
| Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation | Q59062494 | ||
| The structure and composition of the myxoviruses. I. Electron microscope studies of the structure of myxovirus particles by negative staining techniques | Q78770290 | ||
| Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial | Q84747835 | ||
| Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin | Q27671619 | ||
| A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin | Q27676298 | ||
| Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors | Q27677104 | ||
| Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site | Q27679927 | ||
| Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus | Q27683156 | ||
| Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection | Q27701887 | ||
| A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen | Q27701889 | ||
| Accurate design of megadalton-scale two-component icosahedral protein complexes | Q27722473 | ||
| Structure of influenza haemagglutinin at the pH of membrane fusion | Q27730888 | ||
| Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution | Q28131812 | ||
| Ab initio protein structure prediction of CASP III targets using ROSETTA | Q28145980 | ||
| The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses | Q28384333 | ||
| Spherical influenza viruses have a fitness advantage in embryonated eggs, while filament-producing strains are selected in vivo | Q28391618 | ||
| Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies | Q28396120 | ||
| Macromolecular modeling with rosetta | Q29615856 | ||
| Live attenuated influenza vaccine | Q30209252 | ||
| Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection | Q30209769 | ||
| Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. | Q30351356 | ||
| H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge | Q30356429 | ||
| Divergent H7 immunogens offer protection from H7N9 virus challenge. | Q30358196 | ||
| Influenza virus pleiomorphy characterized by cryoelectron tomography | Q30358499 | ||
| Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. | Q30364514 | ||
| Single-particle cryo-EM data acquisition by using direct electron detection camera. | Q30364614 | ||
| Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process. | Q30365791 | ||
| Optimized negative staining: a high-throughput protocol for examining small and asymmetric protein structure by electron microscopy. | Q30365949 | ||
| Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine. | Q30369136 | ||
| Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. | Q30373887 | ||
| Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). | Q30382351 | ||
| Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting | Q30395224 | ||
| Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines | Q30404218 | ||
| Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico | Q30405652 | ||
| Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice | Q30418452 | ||
| Traditional and new influenza vaccines | Q37035833 | ||
| Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles | Q37060947 | ||
| Design of a hyperstable 60-subunit protein dodecahedron. [corrected] | Q37095646 | ||
| Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes | Q37140197 | ||
| Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact | Q37323172 | ||
| Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus | Q37369509 | ||
| The need for quadrivalent vaccine against seasonal influenza | Q37780348 | ||
| Understanding and learning from the success of prophylactic human papillomavirus vaccines. | Q38041983 | ||
| Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium | Q38118946 | ||
| Bat-derived influenza-like viruses H17N10 and H18N11. | Q38192283 | ||
| Filamentous influenza viruses. | Q38882756 | ||
| Immune history and influenza virus susceptibility | Q39088963 | ||
| Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes. | Q40075978 | ||
| The Doctrine of Original Antigenic Sin: Separating Good From Evil | Q40248207 | ||
| Architecture of ribonucleoprotein complexes in influenza A virus particles | Q40325038 | ||
| Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform | Q40382460 | ||
| Structural studies of influenza virus RNPs by electron microscopy indicate molecular contortions within NP supra-structures | Q40398413 | ||
| Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies | Q30430925 | ||
| Structural organization of a filamentous influenza A virus | Q30495070 | ||
| Visualization and Sequencing of Membrane Remodeling Leading to Influenza Virus Fusion. | Q30784849 | ||
| Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets | Q33743763 | ||
| In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen | Q33820732 | ||
| A negative staining method for high resolution electron microscopy of viruses | Q33970535 | ||
| Envelope structure of Semliki Forest virus reconstructed from cryo-electron micrographs | Q34051255 | ||
| Structural changes in Influenza virus at low pH characterized by cryo-electron tomography | Q34132726 | ||
| A negative stain for electron microscopic tomography | Q34172086 | ||
| Influenza virus M2 protein has ion channel activity | Q34248853 | ||
| The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) | Q34249741 | ||
| Cryo-electron microscopy of viruses | Q34255422 | ||
| Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution | Q34271513 | ||
| HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions | Q34507291 | ||
| At low pH, influenza virus matrix protein M1 undergoes a conformational change prior to dissociating from the membrane | Q34610979 | ||
| Morphology of influenza B/Lee/40 determined by cryo-electron microscopy | Q35091674 | ||
| Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures | Q35105223 | ||
| Raising expectations for subunit vaccine | Q35452705 | ||
| Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy | Q36125875 | ||
| Electron tomography of viruses | Q36238946 | ||
| FluBlok, a recombinant hemagglutinin influenza vaccine | Q36251189 | ||
| A review of clinical trials of human papillomavirus prophylactic vaccines | Q36259403 | ||
| Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection | Q36515143 | ||
| Isolation and properties of an RNA polymerase from influenza virus-infected cells | Q36550716 | ||
| Transcription of the Influenza Ribonucleic Acid Genome by a Virion Polymerase III. Completeness of the Transcription Process | Q36589771 | ||
| Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site | Q36590540 | ||
| Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses | Q36693991 | ||
| Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate. | Q36727656 | ||
| HIV-1 envelope glycoprotein trimers display open quaternary conformation when bound to the gp41 membrane-proximal external-region-directed broadly neutralizing antibody Z13e1 | Q36911710 | ||
| Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies | Q36911722 | ||
| The hemifusion structure induced by influenza virus haemagglutinin is determined by physical properties of the target membranes | Q36926306 | ||
| Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms | Q36973969 | ||
| The development of cryo-EM into a mainstream structural biology technique | Q37019898 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P577 | publication date | 2018-05-25 | |
| P1433 | published in | Vaccines | Q27725508 |
| P1476 | title | Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy | |
| P478 | volume | 6 |
| Q66679228 | Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases |
| Q92406730 | Cryo-EM cools down swine fever |
| Q92898478 | Immunoelectron Microscopy of Viral Antigens |
| Q90431940 | Separation of influenza virus-like particles from baculovirus by polymer grafted anion-exchanger |
| Q57166818 | The Future of Influenza Vaccines: A Historical and Clinical Perspective |
Search more.